Physician profile
Rhoda Smith
NPI 1568564771
$477.29
in general payments reported to CMS, 2019-2025
9 companies · $58.82 in 2025
The $58.82 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.58 · 2021: $130 · 2022: $110 · 2024: $165 · 2025: $58.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $138.28 | 2024 | Hemoblast Bellows |
| Boston Scientific Corporation | $129.73 | 2020-2022 | |
| Medtronic, INC. | $43.74 | 2021-2022 | |
| Tela Bio, INC. | $43.03 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $40.28 | 2025 | Exparel |
| Mauna Kea Technologies, INC. | $26.53 | 2024 | |
| Innocoll Pharmaceuticals Limited | $19.53 | 2022 | |
| Mimedx Group, INC. | $18.54 | 2025 | |
| Hologic INC | $17.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhoda Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.